Mizuho raised the firm’s price target on Intuitive Surgical to $390 from $350 and keeps a Neutral rating on the shares post the Q4 report. With the “big event now out in the open” of the new robot, timing for a full-scale launch and the extent of earnings drag will come into focus, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ISRG:
- Intuitive Surgical (NASDAQ:ISRG) Clears 52-Week High; Da Vinci 5 Coming Soon
- Intuitive Surgical price target raised to $428 from $390 at Citi
- Intuitive (NASDAQ:ISRG) Gains after Better-than-Expected Q4 Results
- Intuitive Surgical Sees FY24 procedure growth 13%-16%
- Intuitive Surgical says da Vinci 5 will join existing robotic surgery portfolio
